SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-018548
Filing Date
2020-04-24
Accepted
2020-04-24 16:44:57
Documents
5
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A tcon-defa14a_20200610.htm DEFA14A 41546
2 GRAPHIC ghpw305njmdw000002.jpg GRAPHIC 66453
3 GRAPHIC ghpw305njmdw000001.jpg GRAPHIC 43676
4 GRAPHIC ghpw305njmdw000004.jpg GRAPHIC 12378
5 GRAPHIC ghpw305njmdw000003.jpg GRAPHIC 21484
  Complete submission text file 0001564590-20-018548.txt   241505
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36818 | Film No.: 20815666
SIC: 2836 Biological Products, (No Diagnostic Substances)